Effect of Alginate and Surfactant on Physical Properties of Oil Entrapped Alginate Bead Formulation of Curcumin

Authors: Arpa Petchsomrit, Namfa Sermkaew, Ruedeekorn Wiwattanapatapee

Abstract:

Oil entrapped floating alginate beads of curcumin were developed and characterized. Cremophor EL, Cremophor RH and Tween 80 were utilized to improve the solubility of the drug. The oil-loaded floating gel beads prepared by emulsion gelation method contained sodium alginate, mineral oil and surfactant. The drug content and % encapsulation declined as the ratio of surfactant was increased. The release of curcumin from 1% alginate beads was significantly more than for the 2% alginate beads. The drug released from the beads containing 25% of Tween 80 was about 70% while a higher drug release was observed with the beads containing Cremophor EL or Cremohor RH (approximately 90%). The developed floating beads of curcumin powder with surfactant provided a superior drug release than those without surfactant. Floating beads based on oil entrapment containing the drug solubilized in surfactants is a new delivery system to enhance the dissolution of poorly soluble drugs.

Keywords: Alginate, curcumin, floating drug delivery, oil entrapped bead.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1089449

References:

[1] B. Gander, K. Ventouras, R. Gurny and E. Doelker. "In vitro dissolution medium with supramicellar surfactant concentration and its relevance for in vivo absorption,” Int. J. Pharm., Vol. 27, no. 1, pp. 117–124, Nov. 1985.
[2] P. Somparn, C. Phisalaphong, S. Nakornchai, S. Unchern and N. P. Morales. "Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives,” Biol. Pharm. Bull., Vol. 30, no. 1, pp. 74-78, Jan. 2007.
[3] X. Wang, Y. Jiang, Y. Wang, M. Huang, C. Ho and Q. Huang. "Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions,” Food. Chem., Vol. 108, no. 2, pp. 419-424, May. 2008.
[4] N. Chainani-Wu. "Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa),” J. Altern. Complement. Med., Vol. 9, no. 1, pp. 161-168, Feb 2003.
[5] K. J. Kim, H. H. Yu, J. D. Cha, S. J. Seo, N. Y. Choi and Y. O. You. "Antibacterial activity of Curcuma longa L. against methicillin-resistant Staphylococcus aureus," Phytother. Res., Vol. 19, no. 7, pp. 599-604, Jul. 2005.
[6] S. Mahattanadul, T. Nakamura, P. Panichayupakaranant, N. Phdoongsombut, K. Tungsinmunkong and P. Bouking. "Comparative antiulcer effect of bisdemethoxycurcumin and curcumin in a gastric ulcer model system,” Phytomedicine, Vol. 16, no. 4, pp. 342-351, Apr. 2009.
[7] U. M. Viradia, A. M. Shenoy, M. S. Rajan, A. R. Shabaraya, A. D. Kothadia and N. H. Patel. "Effect of leukotriene receptor antagonist montelukast along with curcumin against gastric ulceration,” Int. J. Pharm. Sci. Rev. Res., Vol. 3, no. 3, pp. 184-187, 2011.
[8] A. Goel, A. B. Kunnumakkara, B. B. Aggarwal. "Curcumin as "Curecumin": from kitchen to clinic,” Biochem. Pharmacol., Vol. 75, no. 4, pp. 787-809, Feb. 2008.
[9] P. Yoysungnoen, P. Wirachwong, C. Changtam, A. Suksamrarn and S. Patumraj. "Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice,” World. J. Gastroenterol., Vol.14, no. 13, pp. 2003-2009, Arp.2008.
[10] P. Anand, A. B. Kunnumakkara, R. A. Newman, B. B. Aggarwal. "Bioavailability of curcumin: problems and promises,” Mol. Pharm., Vol. 4, no. 6, pp. 807-818, Nov.-Dec. 2007.
[11] P. Ratanajiajaroen, M. Ohshima. "Synthesis, release ability and bioactivity evaluation of chitin beads incorporated with curcumin for drug delivery applications,” J. Microencapsul., Vol. 29, No. 6, pp. 549-558, 2012.
[12] S. Song, Z. Wang, Y. Qian, L. Zhang and E. Luo, "The release rate of curcumin from calcium alginate beads regulated by food emulsifiers," J. Agric. Food. Chem., Vol. 60, no. 17, pp. 4388-4395, May. 2012.
[13] S. Arora, J. Ali, A. Ahuja, R. K. Khar, and S. Baboota. "Floating drug delivery systems: a review,” AAPS Pharm. Sci. Tech., Vol. 6, no. 3, pp. E372–E390, Sep. 2005.
[14] A. D. Khan, M. Bajpai. "Floating drug delivery system: an overview,” Pharm. Tech., Vol. 2, no. 4, pp. 2497-2505, Oct-Dec 2010.
[15] B. N. Singh, K.H. Kim. "Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention,” J. Control. Release., Vol. 63, No. 3, pp. 235-259, Feb. 2000.
[16] Shishu, N. Gupta and N. Aggarwal. "Bioavailability enhancement and targeting of stomach tumors using gastro-retentive floating drug delivery system of curcumin—"a technical note”,” AAPS Pharm. Sci. Tech., Vol. 9, No. 3, pp. 810–813, Sep. 2008.
[17] A. K. Singhal, N. Nalwaya, E. E. Jarald and S. Ahmed. "Colon targeted curcumin delivery using guar gum,” Phcog. Res., Vol 2, no. 2, pp. 82-85, 2010.
[18] R. K. Das, N. Kasoju, U. Bora. "Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells” Nanomedicine., Vol. 6, no. 1, pp. 153-160, Feb. 2010.
[19] S. Mishra, K. Pathak. "Formulation and evaluation of oil entrapped gastroretentive floating gel beads of loratadine,” Acta. Pharm., Vol. 58, no. 2, pp. 187–197, Jun. 2008.
[20] I. Singh, P. Kumar, H. Singh, M. Goyal and V. Rana. "Formulation and evaluation of domperidone loaded mineral oil entrapped emulsion gel (MOEG) buoyant beads,” Acta. Pol. Pharm., Vol. 68, no. 1, pp. 121-126, Jan.-Feb. 2011.
[21] S. Setthacheewakul, S. Mahattanadul, N. Phadoongsombut, W. Pichayakorn, R. Wiwattanapatapee. "Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats,"Eur. J. Pharm. Biopharm., Vol. 76, no. 3, pp. 475-485, Nov. 2010.